GORDIAN PHARMA LIMITED

🏛️Establishedactive
12411459 · ltd · incorporated 2020-01-20
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
🔒Estimated value
Upgrade to see
Turnover
not disclosed
Net worth
book net assets
Opportunity
70/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
Investor take
Pass (distressed without resilience)
Distressed active trading company — structural issues outweigh the discount.

Opportunity 70/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Resolve: 1 insolvency-related filing on record. Filings relating to insolvency, liquidation, or administration exist in the company's history. Review before proceeding. Most likely exit: share sale to pe / searcher (65/100).

Data confidence

Overall: medium (60/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
No iXBRL financials extracted
0
Lenders & charges
Confirmed no charges registered
85
Directors & officers
7 officers (5 active, 7 linked, 7 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
13 connected companies via shared directors
84
Filing history
51 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
70/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
65
Adequate — check latest filings for context.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
64
Some moderate concerns — review flags.
Signal strength
90
Good data coverage for analysis.

Recent activity

Last 30 days
0
filings
Last 90 days
3
filings
  • 2 address
  • 1 resolution
Last 180 days
7
filings
  • 2 address
  • 1 resolution
  • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (33 events)Click to expand
  1. 2026-05-29
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  2. 2026-05-27
    📍
    change-registered-office-situation-company-with-old-jurisdiction-new-jurisdiction
    address · AD05
  3. 2026-04-11
    📄
    resolution
    resolution · RESOLUTIONS
  4. 2026-02-27
    📄
    legacy
    miscellaneous · RP01SH01
  5. 2026-01-26
    📄
    capital-allotment-shares
    capital · SH01
  6. 2026-01-26
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  7. 2025-11-26
    PEAGRAM, Michael John, Dr appointed
    director
  8. 2025-11-20
    📄
    capital-allotment-shares
    capital · SH01
  9. 2025-11-20
    📄
    capital-allotment-shares
    capital · SH01
  10. 2025-11-20
    📄
    capital-allotment-shares
    capital · SH01
  11. 2025-11-20
    📄
    capital-allotment-shares
    capital · SH01
  12. 2025-11-20
    📄
    legacy
    miscellaneous · RP01SH01
  13. 2025-03-17
    📄
    accounts-with-accounts-type-small
    accounts · AA
  14. 2025-03-06
    📄
    capital-allotment-shares
    capital · SH01
  15. 2025-02-12
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC05
  16. 2025-02-03
    📄
    capital-statement-capital-company-with-date-currency-figure
    capital · SH19
  17. 2025-02-03
    📄
    legacy
    capital · SH20
  18. 2025-02-03
    ⚠️
    legacy
    insolvency · CAP-SS
  19. 2025-02-03
    📄
    resolution
    resolution · RESOLUTIONS
  20. 2025-01-10
    📄
    capital-allotment-shares
    capital · SH01
  21. 2024-08-28
    📄
    memorandum-articles
    incorporation · MA
  22. 2024-08-28
    📄
    resolution
    resolution · RESOLUTIONS
  23. 2024-08-21
    📄
    capital-allotment-shares
    capital · SH01
  24. 2024-08-19
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  25. 2024-07-01
    HUDSON, Michael John, Dr resigned
    director
  26. 2021-07-16
    ALEN-BUCKLEY, Michael Ulic Anthony appointed
    director
  27. 2021-07-16
    RICHARDS, William Philip Seymour resigned
    director
  28. 2020-06-30
    RICHARDS, William Philip Seymour appointed
    director
  29. 2020-01-20
    🏢
    Company incorporated
    As GORDIAN PHARMA LIMITED
  30. 2020-01-20
    BEATSON-HIRD, Jonathan Denis appointed
    director
  31. 2020-01-20
    PHILLIPS, Judith Carlyon appointed
    director
  32. 2020-01-20
    WYLLIE, Michael Grant, Dr appointed
    director
  33. 2020-01-20
    HUDSON, Michael John, Dr appointed
    director

Owner dependency

55/100
Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS
  • -5 active directors: Broader management team in place — suggests transferable governance.
  • +Founder age: Director aged approximately 83 — succession pressure is live.

Succession & seller-readiness

60/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • primaryFounder aged 70+: Senior director is approximately 83 years old. Natural succession window is now.

Red flags

1 high · 1 low
1 insolvency-related filing on record
high

Filings relating to insolvency, liquidation, or administration exist in the company's history. Review before proceeding.

Evidence: 2025-02-03: legacy

Multiple registered office changes
low

Multiple address changes in a short period can indicate operational instability or admin disorder.

Group structure

Morvus Technology Limited holds 25-50% — a significant corporate investor but not a controlling parent.

🏛️
Morvus Technology Limited
Corporate parent · holds 25-50% shares
significant stake
GORDIAN PHARMA LIMITED
This company · 12411459

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

1 active beneficial owner
NameSharesVoting rightsNature of controlNotified
Morvus Technology Limited
Corporate entity
2550%
25–50%25-50% shares · 25-50% voting20/01/2020

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Professional services · OX postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
AJ RACING LTD
13774794 · est 2021 · no financials extracted
4y
AJD TAX LIMITED
13320224 · est 2021 · no financials extracted
5y
AJV CONSULT LIMITED
15601750 · est 2024 · no financials extracted
2y
AK DESIGN ATELIER LIMITED
14134836 · est 2022 · no financials extracted
3y
AKSWARD LIMITED
05433208 · est 2005 · no financials extracted
20y
AL3D LIMITED
07915303 · est 2012 · no financials extracted
14y
ALATE BUSINESS GROWTH LTD
11709929 · est 2018 · no financials extracted
7y
ALDWYNS LIMITED
16061110 · est 2024 · no financials extracted
1y
ALETHIO THERAPEUTICS LIMITED
13509030 · est 2021 · no financials extracted
4y
ALEX CRESSWELL PLANNING CONSULTANCY LTD
15996005 · est 2024 · no financials extracted
1y
ALEX NICHOLS CONSULTING LIMITED
09127020 · est 2014 · no financials extracted
11y
ALEXANDER BARNES IP LIMITED
16132627 · est 2024 · no financials extracted
1y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2020-01-20
Jurisdictionengland-wales
Primary SIC72110 — Research and experimental development on biotechnology

Registered office

Wood Centre For Innovation Stansfeld Park
Quarry Road, Headington
Oxford
OX3 8SB

Filing status

Accounts
Next due: 2026-07-31
Last made up to: 2024-10-31
Confirmation statement
Next due: 2027-01-28
Last: 2026-01-14

Officers (5 active · 2 resigned)

ALEN-BUCKLEY, Michael Ulic Anthony
director · ~69y · appointed 2021-07-16
View their other companies + combined net worth →
Active
BEATSON-HIRD, Jonathan Denis
director · ~66y · appointed 2020-01-20
View their other companies + combined net worth →
Active
PEAGRAM, Michael John, Dr
director · ~83y · appointed 2025-11-26
View their other companies + combined net worth →
Active
PHILLIPS, Judith Carlyon
director · ~62y · appointed 2020-01-20
View their other companies + combined net worth →
Active
WYLLIE, Michael Grant, Dr
director · ~75y · appointed 2020-01-20
View their other companies + combined net worth →
Active
HUDSON, Michael John, Dr
director · ~68y · appointed 2020-01-20 · resigned 2024-07-01
Resigned
RICHARDS, William Philip Seymour
director · ~66y · appointed 2020-06-30 · resigned 2021-07-16
Resigned

Click a director name to see their full track record across all companies.

Recent filings (51 total)

change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2026-05-29
change-registered-office-situation-company-with-old-jurisdiction-new-jurisdiction
address · AD05
2026-05-27
resolution
resolution · RESOLUTIONS
2026-04-11
confirmation-statement-with-updates
confirmation-statement · CS01
2026-02-27
legacy
miscellaneous · RP01SH01
2026-02-27
capital-allotment-shares
capital · SH01
2026-01-26
appoint-person-director-company-with-name-date
officers · AP01
2026-01-26
capital-allotment-shares
capital · SH01
2025-11-20
capital-allotment-shares
capital · SH01
2025-11-20
capital-allotment-shares
capital · SH01
2025-11-20
capital-allotment-shares
capital · SH01
2025-11-20
legacy
miscellaneous · RP01SH01
2025-11-20
accounts-with-accounts-type-small
accounts · AA
2025-03-17
capital-allotment-shares
capital · SH01
2025-03-06
confirmation-statement-with-updates
confirmation-statement · CS01
2025-02-12